Core Points - On November 19, 2025, the company announced that its stock price had experienced a cumulative increase of over 20% in the closing price over two consecutive trading days, which is classified as an abnormal trading fluctuation according to the Shanghai Stock Exchange regulations [2] - The company is in the process of a significant asset restructuring, which involves the issuance of shares and cash payment to acquire 100% equity of Shandong Tianyi Chemical Co., Ltd. (referred to as "Tianyi Chemical") [2] - The board of directors has approved this acquisition, but it still requires approval from the company's shareholders, indicating that there are uncertainties surrounding this matter [2] - The company urges investors to be aware of trading risks in the secondary market and to make rational decisions regarding their investments [2]
亚星化学:股票交易异常波动公告